This podcast will contain summaries of veterinary journal articles from various journals. It is meant to provide another source to access information when you are not able to read through the article. For disclosure, articles are summarized and read using AI. There is oversight as each script is read and modified prior to publication.
Veterinary Medicine Digest (Utilizing AI to expand information availability)
Claim This Podcastby shinndvm
34 episodes
Updated Daily
Accepts GuestsHas Sponsors
Podcast Overview
This podcast will contain summaries of veterinary journal articles from various journals. It is meant to provide another source to access information when you are not able to read through the article. For disclosure, articles are summarized and read using AI. There is oversight as each script is read and modified prior to publication.
Language
🇺🇲
Publishing Since
7/13/2025
Reach the team behind Veterinary Medicine Digest (Utilizing AI to expand information availability)
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
December 18, 2025
Canine Muscular Dystrophy Summary
<p>This is a summary of the episode Canine Muscular Dystrophy. </p>
December 18, 2025
Canine Muscular Dystrophy
<p>Delve into the crucial role of canine models in advancing treatments for Duchenne Muscular Dystrophy (DMD), a devastating, X-linked muscle-wasting disease. This summary covers the latest findings across therapeutic strategies, diagnostic biomarkers, and underlying disease mechanisms derived from sophisticated dog models like the Golden Retriever Muscular Dystrophy (GRMD), Canine X-linked Muscular Dystrophy in Japan (CXMDj), and the DE50-MD dogs.Gene Therapy Breakthroughs and Treatment TargetsResearch in the DE50-MD model, which mimics a common human mutational hotspot, demonstrates remarkable success in gene editing. Systemic intravenous delivery of Adeno-Associated Virus serotype nine (AAV9) encoding CRISPR-Cas9 components successfully restored Dystrophin protein widely throughout the body. The high dose resulted in up to ninety-two percent of wild-type Dystrophin levels in the heart and significant restoration in skeletal muscles, such as seventy percent in the cranial tibialis and fifty-eight percent in the diaphragm. Histologically, treated muscles showed improvement with reduced necrosis and fibrosis.Beyond gene correction, metabolic strategies offer therapeutic potential. GRMD dogs exhibit significantly reduced Nicotinamide Adenine Dinucleotide NAD content in striated muscles, an energy cofactor depleted due to altered synthesis and increased consumption by poly(ADP-ribose) polymerases (PARPs). Short-term oral supplementation with nicotinamide successfully boosted muscle NDA levels and led to a mild beneficial effect, including a stabilization trend in clinical scores and a significant improvement in the maximal inspiratory/expiratory flows ratio, suggesting modest stabilization of respiratory function.Advanced Diagnostics and Objective BiomarkersObjective measures are crucial for quantifying therapeutic efficacy. The gold standard for assessing skeletal muscle function in preclinical trials is the Eccentric Contraction Decrement (ECD) protocol, which measures the rapid loss of force (torque decrement) when dystrophic muscle lengthens under contraction. Clinically, Dystrophin deficient dogs often present with markedly and persistently elevated Creatine Kinase (CK) levels. Symptoms can include macroglossia (enlarged tongue), reduced mandibular extension, dysphagia (swallowing difficulty), and regurgitation. Radiographic signs often include diaphragmatic thickening and an axial gastro-esophageal hiatal hernia. Clinicians must note that volatile inhalant anesthetic agents can trigger hyperkalemic cardiac arrest due to membrane instability in Dystrophin deficient muscle fibers; therefore, total intravenous anesthesia is recommended. Referenced Articles:• Replenishing NAD+ content reduces aspects of striated muscle disease in a dog model of Duchenne muscular dystrophy• Digital Outcome Measures for Gait and Spontaneous Locomotor Activity in Dystrophic Dogs• Cardio-Physiological Evaluations in a Dog Model with Duchenne Muscular Dystrophy• Canine Model of Duchenne Muscular Dystrophy• Exploring Desmin as a Potential Modifier in Duchenne Muscular Dystrophy–Associated Cardiomyopathy• Congenital muscular dystrophy in a dog with a LAMA2 gene deletion• Radiographic, MRI, and CT findings in a young dog with Becker-like muscular dystrophy• Longitudinal assessment of skeletal muscle functional mechanics in the DE50-MD dog model of Duchenne muscular dystrophy• Dystrophin-Deficient Muscular Dystrophy in a Family of Shiba Inu Dogs with a Complex Deletion Encompassing DMD Exon 5• Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy• Lymphatic dysfunction is linked to disease pathogenesis in Duchenne muscular dystrophy animal models</p>
December 17, 2025
Cryoprecipitates and Desmopression in Dogs and Cats Summary
<p>Cryoprecipitates and Desmopression in Dogs and Cats Summary</p>
34 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Veterinary Medicine Digest (Utilizing AI to expand information availability)
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Veterinary Medicine Digest (Utilizing AI to expand information availability)?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.